Strategic partnerships StoreMyTumor already engages in external partnerships, such as with the American Breast Cancer Foundation. This indicates receptivity to collaboration with nonprofits, clinics, or disease-focused organizations that can expand reach and credibility for bundled preservation services.

Clinical integration The service centers on preserving viable tumor tissue to support personalized treatment and clinical trials. There is a sales opportunity in offering integrated preservation solutions to hospitals, cancer centers, and biopsy/surgery teams seeking to improve access to tissue for diagnostics, trials, and targeted therapies.

Private facility appeal As the largest and most experienced private tumor bank, StoreMyTumor can position premium, owner-controlled tissue stewardship to high-value patients and clinics. Target enrollment and referral programs could be built with clinics seeking patient-centric tissue ownership and long-term sample viability.

Market expansion potential With a single-employee footprint currently and revenues under one million, there is room to scale through channel partnerships, white-label offerings, or service tier expansion (storage formats, rapid processing, and cryopreservation options) to reach mid-size hospitals and specialty clinics.

Technology leverage The underutilized tech stack and privacy/security credentials (SSL, Cloudflare, OpenResty) can be used to market a secure, compliant tissue storage platform. Highlighting data protection, ownership management, and access controls can attract hospital IT and risk officers seeking compliant biobanking solutions.